Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative

Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative

Read More

Vitro Biopharma Obtains CLIA Certification

Vitro Biopharma Obtains CLIA Certification

Read More

Vitro Biopharma Receives Approval for a Stem Cell Clinical Trial for Musculoskeletal Conditions by the Bahamas Ministry of Health

Vitro Biopharma Receives Approval for a Stem Cell Clinical Trial for Musculoskeletal Conditions by the Bahamas Ministry of Health

Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial entitled “Vitro Biopharma Allogeneic Mesenchymal Stem Cell Therapy For Musculoskeletal Conditions.

Read More


Key Advances in Stem Cell Technology During 2018 Expand Vitro Biopharma Markets

Key Advances in Stem Cell Technology During 2018 Expand Vitro Biopharma Markets

2018 Saw accelerated understanding of the roles of stem cells in health and disease. The Shruti Naik lab at the Rockefeller University Howard Hughes Institute demonstrated close interrelationship between immune cells and stem cells. Stem cells store memories of prior activation by stress through specific epigenetic modulation.

Read More

Vitro Biopharma Receives ISO 9001 Certification of its Quality Management System

Vitro Biopharma Receives ISO 9001 Certification of its Quality Management System

Vitro Biopharma (“Vitro”) one of the world’s emerging biotechnology companies focused on Umbilical Cord Mesenchymal Stem Cell (“MSC's”) research and clinical products has been awarded Certification to the International Organization for Standard Quality Control Procedures.

Read More